Clinical Trials Directory

Trials / Conditions / Refractory Angina Pectoris

Refractory Angina Pectoris

14 registered clinical trials studyying Refractory Angina Pectoris — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingAssessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
NCT05711849
Barts & The London NHS TrustPhase 2
WithdrawnCardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve
NCT03438500
Storz Medical AGN/A
UnknownEfficacy of Spinal Cord Stimulation in Patients With Refractory Angina Pectoris
NCT04915157
Catharina Ziekenhuis EindhovenN/A
CompletedIMR Evaluation in Patients with Coronary Sinus Reducer Implantation (INROAD Study)
NCT05174572
Consorzio Futuro in RicercaN/A
CompletedAdenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectori
NCT03039751
Kuopio University HospitalPhase 2
CompletedCoROnary SinuS Reducer implantatiOn for ischemiA reDuction
NCT04121845
University Medical Centre LjubljanaN/A
UnknownEffect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients
NCT02499250
Navy General Hospital, BeijingN/A
UnknownEfficacy of Extracorporeal Shockwave Myocardial Revascularization
NCT01711099
Salus Ltd.N/A
CompletedEfficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capac
NCT01508910
Lisata Therapeutics, Inc.Phase 3
UnknownExtracorporeal Shock Wave Therapy for the Treatment of Ischemic Heart Disease
NCT01241968
MedispecPhase 2
SuspendedExtracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris
NCT01567592
MedispecPhase 1
CompletedExtracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris
NCT01219218
MedispecPhase 1
UnknownExtracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris
NCT01567644
MedispecPhase 1
CompletedExtracorporeal Shockwave Therapy for the Treatment of Refractory Angina Pectoris
NCT00662727
MedispecPhase 2